-transparent.png){kind=logo}
Recent theoretical work has suggested that radiochemical impurities can significantly alter the binding results for highly protein-bound drugs. We compared protein binding of warfarin by ultrafiltration and equilibrium dialysis with 98% radiochemically pure [14C]warfarin. Ultrafiltration and equilibrium dialysis were performed at 37 degrees C and pH 7.45 on the plasma of patients receiving chronic warfarin therapy. Binding to plasma from seven patients were measured in duplicate by both a nonspecific radioisotopic technique and a specific HPLC technique. The nonspecific technique gave percentage of free warfarin values of 1.84 +/- 0.11 (mean +/- SD) and 1.59 +/- 0.14 for ultrafiltration and equilibrium dialysis, respectively. The HPLC procedure yielded a percentage of free warfarin by ultrafiltration of 0.969 +/- 0.203 and a value of 0.690 +/- 0.095 by equilibrium dialysis (p less than 0.05). The HPLC procedure for protein binding was performed on plasma samples from 12 additional patients and yielded a percentage of free warfarin of 1.01 +/- 0.69 by ultrafiltration and 0.44 +/- 0.34 by equilibrium dialysis (p less than 0.05). It can be concluded that radiochemical impurities may lead to significant overestimation of the percentage of free warfarin. Ultrafiltration yielded a higher percentage of free warfarin than did equilibrium dialysis, but the ability to distinguish binding differences among patients was similar.
D Mungall, and
Y Y Wong, and
R L Talbert, and
M H Crawford, and
J Marshall, and
D W Hawkins, and
T M Ludden
January 1984,
Journal of clinical pharmacology,
D Mungall, and
Y Y Wong, and
R L Talbert, and
M H Crawford, and
J Marshall, and
D W Hawkins, and
T M Ludden
October 1976,
Journal of clinical pharmacology,
D Mungall, and
Y Y Wong, and
R L Talbert, and
M H Crawford, and
J Marshall, and
D W Hawkins, and
T M Ludden
May 1974,
Journal of pharmaceutical sciences,
D Mungall, and
Y Y Wong, and
R L Talbert, and
M H Crawford, and
J Marshall, and
D W Hawkins, and
T M Ludden
February 1995,
British journal of clinical pharmacology,
D Mungall, and
Y Y Wong, and
R L Talbert, and
M H Crawford, and
J Marshall, and
D W Hawkins, and
T M Ludden
November 1984,
Journal of pharmaceutical sciences,
D Mungall, and
Y Y Wong, and
R L Talbert, and
M H Crawford, and
J Marshall, and
D W Hawkins, and
T M Ludden
September 1982,
The Proceedings of the Nutrition Society,
D Mungall, and
Y Y Wong, and
R L Talbert, and
M H Crawford, and
J Marshall, and
D W Hawkins, and
T M Ludden
January 1977,
Clinical pharmacokinetics,
D Mungall, and
Y Y Wong, and
R L Talbert, and
M H Crawford, and
J Marshall, and
D W Hawkins, and
T M Ludden
December 1981,
Journal of pharmaceutical sciences,
D Mungall, and
Y Y Wong, and
R L Talbert, and
M H Crawford, and
J Marshall, and
D W Hawkins, and
T M Ludden
October 1975,
Research communications in chemical pathology and pharmacology,
D Mungall, and
Y Y Wong, and
R L Talbert, and
M H Crawford, and
J Marshall, and
D W Hawkins, and
T M Ludden
January 1991,
Peptides,
